Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II immunogenicity and safety study of MenACYW quadrivalent meningococcal conjugate vaccine in healthy toddlers
2014-004367-20Phase 2Completed
- Sponsor
- Sanofi
- Start
- Dec 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, single-arm trial of Meningococcal ACWY conjugate vaccine in meningococcal disease, sponsored by Sanofi. Primary endpoint: Immunogenicity. Started Dec 2014; status: completed.
02
Drugs
Meningococcal ACWY conjugate vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on 2014-004367-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004367-20.